Duke Basketball Grad Sion James Looks Like Literal Draft Steal - Sports Illustrated
4 days ago • Google News
Sionna Therapeutics, Inc. Common Stock (SION)
US$ 12.14-3.65%
Price Chart
Key Statistics
Market Cap
$ 0
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
71.28K
52W High
$ 25.19
52W Low
$ 7.25
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
N/A
200-Day MA
N/A
52 Week High
25.19
52 Week Low
7.255
About SION
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).
Employees
48
Headquarters
Waltham, MA
CEO
Mr. Michael Cloonan M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg